نتایج جستجو برای: medullary thyroid cancer

تعداد نتایج: 982512  

2016
Francesco Frasca

Poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer (ATC) are rare but highly aggressive malignancies with an extremely short survival. Poor prognosis is due to their unlimited growth, invasion, migration and resistance to common anticancer therapies. Advances in understanding the molecular alterations in thyroid carcinomas led to development of new therapeutic strategies ...

Journal: :The Laryngoscope 2010
Christian P Hasney Ronald G Amedee

With fewer than 40 cases described in the otolaryngology literature, mixed medullary papillary thyroid carcinoma represents a rare but phenotypically distinct tumor. While isolated medullary carcinoma may be admixed with normal follicular structures, true mixed carcinoma displays morphological and immunological characteristics of medullary and papillary carcinoma within a single lesion. We repo...

2012
Eun Ju Son Vânia Nosé

Follicular cell-derived well-differentiated thyroid cancer, papillary (PTC) and follicular thyroid carcinomas comprise 95% of all thyroid malignancies. Familial follicular cell-derived well-differentiated thyroid cancers contribute 5% of cases. Such familial follicular cell-derived carcinomas or non-medullary thyroid carcinomas (NMTC) are divided into two clinical-pathological groups. The syndr...

2012
Dario Giuffrida Angela Prestifilippo Alessia Scarfia Daniela Martino Stefania Marchisotta

Thyroid cancer is the most common endocrine tumor. Thyroidectomy, radioactive iodine, and TSH suppression represent the standard treatment for differentiated thyroid cancer. Since chemotherapy has been shown to be unsuccessful in case of advanced thyroid carcinomas, the research for new therapies is fundamental. In this paper, we reviewed the recent literature reports (pubmed, medline, EMBASE d...

2012
Friedhelm Raue Karin Frank-Raue

Multiple endocrine neoplasia type 2 is an autosomal-dominant hereditary cancer syndrome caused by missense gain-of-function mutations of the rearranged during transfection proto-oncogene, which encodes the receptor tyrosine kinase, on chromosome 10. It has a strong penetrance of medullary thyroid carcinomas and can be associated with bilateral pheochromocytoma and primary hyperparathyroidism. M...

2009
Sergio PA Toledo Delmar M Lourenço Marcelo Augusto Santos Marcos R Tavares Rodrigo A Toledo Joya Emilie de Menezes Correia-Deur

Hypercalcitoninemia has frequently been reported as a marker for medullary thyroid carcinoma. Currently, calcitonin measurements are mostly useful in the evaluation of tumor size and progression, and as an index of biochemical improvement of medullary thyroid carcinomas. Although measurement of calcitonin is a highly sensitive method for the detection of medullary thyroid carcinoma, it presents...

Journal: :Journal of the National Comprehensive Cancer Network : JNCCN 2014
R Michael Tuttle Robert I Haddad Douglas W Ball David Byrd Paxton Dickson Quan-Yang Duh Hormoz Ehya Megan Haymart Carl Hoh Jason P Hunt Andrei Iagaru Fouad Kandeel Peter Kopp Dominick M Lamonica William M Lydiatt Judith McCaffrey Jeffrey F Moley Lee Parks Christopher D Raeburn John A Ridge Matthew D Ringel Randall P Scheri Jatin P Shah Steven I Sherman Cord Sturgeon Steven G Waguespack Thomas N Wang Lori J Wirth Karin G Hoffmann Miranda Hughes

These NCCN Guidelines Insights focus on some of the major updates to the 2014 NCCN Guidelines for Thyroid Carcinoma. Kinase inhibitor therapy may be used to treat thyroid carcinoma that is symptomatic and/or progressive and not amenable to treatment with radioactive iodine. Sorafenib may be considered for select patients with metastatic differentiated thyroid carcinoma, whereas vandetanib or ca...

2011
Mehr Sadat Alavi Negar Azarpira

INTRODUCTION Papillary thyroid carcinoma and medullary thyroid carcinoma are two different thyroid neoplasia. The simultaneous occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma as a collison tumor with metastases from both lesions in the regional lymph nodes is a rare phenomenon. CASE PRESENTATION A 32-year-old Iranian man presented with a fixed anterior neck mass. Ult...

Journal: :Endocrinology & metabolism international journal 2022

Thyroid cancer accounts for approximately 3% of all new diagnoses per year globally.1 Papillary thyroid carcinoma (PTC) is the most common type, followed by follicular (FTC).1 Recently, simultaneous appearance different histological variants in same patient has been reported, being called combined pattern cancer, mixed tumors, hybrid tumors or compound gland.2 Epidemiologically, reported less t...

Journal: :Archives of surgery 2009
Sarah Y Boostrom Clive S Grant Geoffrey B Thompson David R Farley Melanie L Richards Tanya L Hoskin Ian D Hay

HYPOTHESIS Assessing prognosis for medullary thyroid cancer remains challenging and inexact. We hypothesize that the 1997 TNM staging criteria, especially for stage IV, are more accurate than the current 2002 staging system. DESIGN Retrospective cohort study. SETTING Tertiary referral center. PATIENTS One hundred seventy-three patients surgically treated for medullary thyroid cancer from ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید